Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist. By: Physicians Total Care, Tulsa, OK --- NDC 5...

FDA Drug Recall #D-499-2013 — Class III — March 18, 2013

Recall Summary

Recall Number D-499-2013
Classification Class III — Low risk
Date Initiated March 18, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Physicians Total Care, Inc.
Location Tulsa, OK
Product Type Drugs
Quantity 6 cards of 28 tablets

Product Description

Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist. By: Physicians Total Care, Tulsa, OK --- NDC 54868-4814-0, MFG By TEVA Pharmaceuticals USA, Sellersville, PA

Reason for Recall

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

Distribution Pattern

MO

Lot / Code Information

Physicians Total Care Lots: 6Z4C Exp. 10/31/2013

Other Recalls from Physicians Total Care, Inc.

Recall # Classification Product Date
D-0237-2015 Class II CEPHALEXIN MONOHYDRATE CAPSULES,USP, 500 mg, 20... Sep 22, 2014
D-390-2014 Class II Carisoprodol IV ( Carisoprodol Tablets USP) 350... Nov 22, 2013
D-0239-2015 Class III Loratadine 24 HR-OTC,10 mg, 30-count bottle, Ma... Sep 11, 2013
D-826-2013 Class II Belladonna Alkaloids/PB (Belladonna Alkaloids /... Jun 17, 2013
D-596-2013 Class III Voltaren 1% Gel, 100 gm tube, Rx only, Dist By:... Mar 2, 2013

Frequently Asked Questions

Nitrosamines are probable human carcinogens — they can increase cancer risk with long-term exposure above certain thresholds, but they do not cause immediate harm from taking a single dose. The FDA calculates an acceptable daily intake (ADI) for each nitrosamine compound, and recalls are triggered when levels exceed this threshold. If you have been taking a recalled product, the FDA generally advises against abruptly stopping your medication (especially for critical conditions like blood pressure or diabetes) until you consult your doctor. The incremental cancer risk from short-term exposure is very small.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.